Farallon Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,920,000
| Closed | -$207M | – | 105 |
|
|
2018
Q2 | $207M | Buy |
2,920,000
+1,100,000
| +60% | +$77.9M | 1.28% | 23 |
|
|
2018
Q1 | $137M | Buy |
+1,820,000
| New | +$137M | 0.95% | 29 |
|
|
2017
Q4 | – | Sell |
-945,000
| Closed | -$76.6M | – | 83 |
|
|
2017
Q3 | $76.6M | Buy |
+945,000
| New | +$76.6M | 0.68% | 37 |
|
|
2017
Q1 | – | Sell |
-135,000
| Closed | -$9.67M | – | 72 |
|
|
2016
Q4 | $9.67M | Buy |
+135,000
| New | +$9.67M | 0.11% | 56 |
|
|
2015
Q3 | – | Sell |
-67,500
| Closed | -$7.9M | – | 87 |
|
|
2015
Q2 | $7.9M | Buy |
+67,500
| New | +$7.9M | 0.11% | 72 |
|